Search results
Results from the WOW.Com Content Network
The approval was updated in September 2021, to include people aged twelve and older. [14] The Moderna Spikevax COVID-19 vaccine was authorized in Canada in September 2021, for people aged 12 and older. [22] [4] [182] The Moderna Spikevax COVID-19 vaccine was authorized in the US in January 2022, for people aged 18 and older. [1] [38] [41]
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States.The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
The COVID-19 vaccine produced by Moderna is set to be approved as early as this week by the U.S. Food and Drug Administration, a report said Tuesday. Moderna “has provided adequate information ...
The CDC approved Pfizer/BioNTech's (PFE/BNTX) bivalent COVID-19 booster for children ages 5-11 and Moderna's bivalent booster for ages 6-17 Wednesday, expanding access to protection against ...
The FDA and CDC have approved new bivalent vaccines by Pfizer and Moderna that target both the original strain of COVID-19 and Omicron subvariants. New Omicron-targeting COVID-19 boosters are ...
Moderna is asking federal regulators for full approval of its COVID-19 vaccine for people 18 and older, the company announced Tuesday.
In a widely anticipated move, and following several countries' earlier approval, the Food and Drug Administration approved the use of Pfizer and Moderna booster shots today, for certain...